Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.

By S. Diem, S. Schmid, M. Krapf, L. Flatz, D. Born, W. Jochum, A. Templeton, M. Früh. Lung Cancer, 2017

898 citations recorded by the source corpus.

Subfields: Oncology